INSIGHT

Healthcare and pharma M&A in Vietnam: key considerations for foreign investors

By Linh Bui, Hien Nguyen, Ngan Tran, Anh Duong
Capital Markets Mergers & Acquisitions Private Equity Vietnam

Legal framework and structuring options for foreign investors

Vietnam’s healthcare and pharmaceutical sectors are entering a defining decade. Demand for high‑quality care is accelerating, driven by an ageing population, rising incomes and a government eager to modernise the system. This momentum has created a rare window for foreign investors: a market with strong fundamentals, increasing private‑sector participation and a steady pipeline of acquisition opportunities.

Yet, beneath the surface lies a regulatory environment that is intricate, fast‑evolving and highly sector‑specific. Understanding how foreign ownership rules, licensing requirements and operational constraints interact is essential for shaping a deal that is both compliant and commercially viable.

This Insight provides a practical overview of the key legal issues foreign investors should consider when entering these sectors in Vietnam.